Sign in

Cristian Ruiz-Moreno

@ccruizm.bsky.social
49 followers 211 following 23 posts

Cancer and molecular biology PhD candidate | Stunnenberg Lab | Prinses Maxima Centrum & Radboud University Nijmegen

PostsRepliesMedia
Cristian Ruiz-Moreno @ccruizm.bsky.social · 26/01/2026
Huge thanks to my co–first author Raphael Collot, our supervisors Anne Rios & Hendrik Stunnenberg, all co-authors, collaborators, funding agencies, patients & families who made this work possible. We’d love to hear your feedback and thoughts! 23/n
010
Cristian Ruiz-Moreno @ccruizm.bsky.social · 26/01/2026
We are committed to making our data FAIR and openly accessible. Processed data are freely available on Zenodo! 🌐 Processed data (Zenodo): zenodo.org/deposit/1706... 💻 Code (coming soon): github.com/ccruizm/pHGG... 22/n
zenodo.org
Zenodo
100
Cristian Ruiz-Moreno @ccruizm.bsky.social · 26/01/2026
We hope pHGGmap becomes a community resource for discovering additional vulnerabilities and uncovering new biology — similar in spirit to what GBmap has provided for adult GB😊 — especially in tumor-reactive states (PM/WR-like) and the RG-like complement axis driving invasion. 21/n
110
Cristian Ruiz-Moreno @ccruizm.bsky.social · 26/01/2026
Beyond what I could cover here, the study also contains interesting insights into epigenetic plasticity and state transitions. I encourage you to dive into the full manuscript for more details. 20/n
100
Cristian Ruiz-Moreno @ccruizm.bsky.social · 26/01/2026
Take-home: pHGG biology is organized into repeatable cancer–myeloid ecosystems, and successful therapy may require niche-aware immune modulation (lipid-laden TAMCs vs microglia vs complement-TAMCs) rather than “one-size-fits-all” immunotherapy. 19/n
110
Cristian Ruiz-Moreno @ccruizm.bsky.social · 26/01/2026
Inspired by evidence that TAMC programs can be reprogrammed, the patient received hydroxychloroquine as adjuvant therapy. This was associated with reduced peritoneal RG-like cells and increased cytotoxic CD8⁺ T cell recruitment/activation. 18/n
100
Cristian Ruiz-Moreno @ccruizm.bsky.social · 26/01/2026
We validate the clinical relevance in a striking case of abdominal metastasis via VP shunt, where ascitic fluid was dominated by RG-like tumor cells and infiltrating myeloid cells that progress toward an immunosuppressive, complement-TAMC-like state. 17/n
100
Cristian Ruiz-Moreno @ccruizm.bsky.social · 26/01/2026
This RG-like/complement-TAMCs ecosystem shares stress-, motility-, and immune-related gene signatures, suggesting a cooperative axis that supports invasion/adaptation. 16/n
100
Cristian Ruiz-Moreno @ccruizm.bsky.social · 26/01/2026
Importantly, we discovered a third niche, stable during disease progression, enriched with stem-like states dominated by RG-like cells and complement-high TAMCs, displaying the highest proliferation + invasiveness (primarily driven by RG-like cells! not OPC-like).🤯 15/n
100
Cristian Ruiz-Moreno @ccruizm.bsky.social · 26/01/2026
Importantly, despite changes in their proportions, both niches remain consistently present across patient samples, highlighting fundamental microenvironments that persist despite therapy-driven remodeling! 14/n
100
Cristian Ruiz-Moreno @ccruizm.bsky.social · 26/01/2026
Both single-cell and spatial data confirmed that tumor-reactive regions align with high hypoxia/stress, while astro-microglial niches sit in lower-stress regions. 13/n
110
Cristian Ruiz-Moreno @ccruizm.bsky.social · 26/01/2026
An astro-microglial niche (abundant in treatment-naïve): AC-like tumor cells + homeostatic/pro-inflammatory TAMCs, which we recently identified in DMG, representing a vulnerable ecosystem to target. doi.org/10.1016/j.cc... 12/n
doi.org
Redirecting
100
Cristian Ruiz-Moreno @ccruizm.bsky.social · 26/01/2026
We highlight three recurring niches: a tumor-reactive niche (prominent post-treatment): PM/WR-like tumor + lipid-laden TAMCs, linked to hypoxia/stress, in line with our previous research doi.org/10.1093/neup... 11/n
doi.org
Single-cell spatial analysis of pediatric high-grade glioma reveals a novel population of SPP1+/GPNMB+ myeloid cells with immunosuppressive and tumor-promoting capabilities
AbstractBackground. Pediatric-type diffuse high-grade gliomas (pHGGs) are a leading cause of pediatric cancer-related mortality. Although immunotherapy off
100
Cristian Ruiz-Moreno @ccruizm.bsky.social · 26/01/2026
Having established the map of cellular states, we next asked how malignant and myeloid programs co-occur and organize together within tumors, moving from individual states to multicellular communities (“niches”), and whether these ecosystems persist or shift with therapy. 10/n
100
Cristian Ruiz-Moreno @ccruizm.bsky.social · 26/01/2026
We characterize TAMCs' programs, defining both homeostatic and inflammatory microglia, as well as multiple programs linked to lipid metabolism, complement signaling, and immune suppression. 9/n
110
Cristian Ruiz-Moreno @ccruizm.bsky.social · 26/01/2026
pHGGs are immunologically “cold” tumors, and the immune landscape is dominated by tumor-associated myeloid cells (TAMCs) rather than lymphocytes, making myeloid states central to tumor–immune interactions. 8/n
100
Cristian Ruiz-Moreno @ccruizm.bsky.social · 26/01/2026
Within tumor-reactive programs, we identify a wound response (WR) and a distinct primitive mesenchymal-like (PM-like) program that exhibits embryonic and primitive features with increased stemness. PM-like appears largely pediatric-specific, especially when compared to adult HGG. 7/n
100
Cristian Ruiz-Moreno @ccruizm.bsky.social · 26/01/2026
Beyond the classic OPC-/OC-/AC-like framework, our atlas resolves very early neurodevelopmental progenitors, including phenotypes previously assumed absent in DMG (e.g., nIPC-like), and delineates an RG-like malignant state that later emerges as a key TME-associated state. 👀 6/n
100
Cristian Ruiz-Moreno @ccruizm.bsky.social · 26/01/2026
Using updated human developmental brain references, we refine malignant-state nomenclature and position tumor cells along an axis of (1) developmental mimicry ↔ (2) tumor-reactive, stress/TME-driven programs. 5/n
100
Cristian Ruiz-Moreno @ccruizm.bsky.social · 26/01/2026
To tackle this, we built pHGGmap: a large, multimodal atlas integrating sc/snRNA-seq, snATAC, Multiome + spatial transcriptomics, across discovery + validation cohorts (over 800,000 analyzed cells from 136 patients). 4/n
100
Cristian Ruiz-Moreno @ccruizm.bsky.social · 26/01/2026
We focused on two aggressive pediatric glioma subgroups: Diffuse Midline Glioma (DMG) and pediatric high-grade glioma H3-wild-type (pDG H3-WT), which arise in distinct brain locations and show unique growth patterns, making them particularly challenging to treat. 3/n
100
Cristian Ruiz-Moreno @ccruizm.bsky.social · 26/01/2026
pHGGs are devastating and still understudied. A major bottleneck has been limited access to diverse samples at scale, which has restricted our ability to capture the full spectrum of cellular states across patients. 2/n
100
Cristian Ruiz-Moreno @ccruizm.bsky.social · 26/01/2026
I’m excited to finally share our research on pediatric high-grade gliomas (pHGG), the result of years of effort integrating single-cell and spatial datasets to offer a fresh perspective on their organization and potential treatment strategies doi.org/10.64898/202... 🧵👇🏼 1/n
131
Reposted by Cristian Ruiz-Moreno
Dr. Jean Fan @jef.works · 03/04/2025
We identify evidence of off-target probe binding in the 10x Genomics #Xenium v1 Human Breast Gene Expression Panel, compromising the accuracy of resulting #singlecell #spatialtranscriptomics profiles See our preprint for more details: www.biorxiv.org/content/10.1... #AcademicSky 🧵👇 1/n
biorxiv.org
Evidence of off-target probe binding in the 10x Genomics Xenium v1 Human Breast Gene Expression Panel compromises accuracy of spatial transcriptomic profiling
The accuracy of spatial gene expression profiles generated by probe-based in situ spatially-resolved transcriptomic technologies depends on the specificity with which probes bind to their intended tar...
14421